Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

2.13
BATS BZX Real-Time Price
As of 11:11am ET
 +0.115 / +5.69%
Today’s Change
1.94
Today|||52-Week Range
7.64
-50.92%
Year-to-Date
Biotech Movers: Cerus, Alexion, NantKwest
May 23 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close2.02
Today’s open2.05
Day’s range1.94 - 2.16
Volume29,363
Average volume (3 months)1,115,451
Market cap$210.0M
Dividend yield--
Data as of 11:11am ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-1.64%
Earnings growth (this year)-0.54%
Earnings growth (next 5 years)+35.00%
Revenue growth (last year)+14.76%
P/E ratioNM
Price/Sales11.28
Price/Book3.62

Competitors

 Today’s
change
Today’s
% change
TIGTigenix NV-0.03-0.18%
CVRSCorindus Vascular Ro...-0.01-0.86%
UTMDUtah Medical Product...-1.00-1.54%
OBLNObalon Therapeutics ...-0.17-1.81%
Data as of 10:56am ET, 05/26/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$39.3M
Annual profit (last year)-$62.9M
Net profit margin-160.17%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
William Mariner Greenman
Vice President-Manufacturing &
Operations
Suzanne Margerum
Corporate headquarters
Concord, California

Forecasts